Trimethylaminuria (TMAU) is a rare genetic disorder characterized by a defect in the metabolism of trimethylamine, which leads to its accumulation in the body and its excretion in the urine, sweat and skin. The condition is usually associated with mutations in the FMO3 (flavin monooxygenase 3) gene, which is responsible for the degradation of trimethylamine, a substance that is formed during the digestion of certain foods such as fish, eggs and legumes. The result of this disorder is a characteristic fishy odor that accompanies patients and can significantly reduce their quality of life due to social stigma and psychological problems.
History of the disease and interesting historical facts
Trimethylaminuria was first described in the medical literature in the 1970s, although the condition may have been known to exist earlier. In 1970, Dr. John LDJ Hegarty presented the first clinical cases of patients complaining of an unpleasant fishy odor after eating certain foods. Over time, not only the genetic features of the condition were identified, but also social aspects such as the impact on the mental health of patients. In 1997, a study conducted in the UK confirmed the existence of TMAU as a hereditary disorder, leading to further research into its genetic causes and treatments.
Epidemiology
According to various studies, the prevalence of trimethylaminuria is approximately 1 case per 100,000 to 200,000 people. However, the numbers may vary depending on the geographic region and ethnicity. In some populations, such as those of Northern European descent, cases of this pathology are more common. This indicates a potential role for genetic predisposition in the incidence of the disease. It is also noted that trimethylaminuria is often reported in the literature as an underrecognized disease, leading to social and psychological problems in patients.
Genetic predisposition to this disease
Trimethylaminuria is located according to the hereditary pattern of the autosomal recessive type. The main gene involved in the pathogenesis of the disease is FMO3, which codes for the enzyme flavin monooxygenase, which plays a key role in the metabolism of trimethylamine. More than 20 different mutations in this gene are known, which lead to a decrease in the production of the enzyme or to its complete destruction. These mutations cause enzyme deficiency, which causes the accumulation of trimethylamine in the body. Some studies suggest that genetic predisposition to TMAU may be associated with certain nomenclatures of polymorphisms that can affect the expression and function of the FMO3 gene.
Risk factors for the development of this disease
The main risk factors for trimethylaminuria are:
- Heredity: Having a family history of the disease can significantly increase your risk.
- Diet: Eating foods rich in trimethylamine, such as fish, eggs, legumes, and some dairy products, may worsen symptoms.
- Genetic mutations: presence of mutations in the FMO3 gene, transmitted from parents.
- Gender: TMAU is more common in women, although men are also at risk.
- Age: Symptoms may begin in adolescence or young adulthood, but their severity may vary depending on individual metabolic characteristics.
Diagnosis of this disease
Diagnosis of trimethylaminuria is based on clinical manifestations and laboratory test results. The main symptoms include:
- Unpleasant fishy smell of sweat and urine.
- Social anxiety and low self-esteem due to smell.
- Problems with social interaction and psychological impact on the patient.
Laboratory tests include:
- Urine analysis for levels of trimethylamine and its metabolites.
- Genetic testing for mutations in FMO3.
Radiological examinations are not used in this case, since the disease does not have morphological changes that could be visualized. Differential diagnosis should be made with similar conditions, such as hemolytic anemia or other metabolic disorders that lead to changes in the smell of sweat and urine.
Treatment
Treatment of trimethylaminuria is multifaceted and includes:
- General treatment: changing your diet, avoiding foods rich in trimethylamine.
- Pharmacological treatment: Prescribing probiotics and antibiotics may help reduce trimethylamine levels by changing the gut microflora. Thiourea may also be used to reduce odor.
- Surgical treatment: In extreme cases, if conservative treatment is ineffective, surgery to correct anatomical changes in the excretory system may be considered.
- Other types of treatment: psychological support and therapy for patients with social and emotional problems.
List of medications used to treat this disease
Main classes of drugs:
- Probiotics: May improve the metabolism of gut bacteria.
- Antibiotics: metronidazole, rifaximin can help reduce trimethylamine levels by changing the composition of the microflora.
- Thiourea: used to reduce the synthesis of trimethylamine in the liver.
Disease monitoring
Monitoring of patients with TMAU includes:
- Regular urine testing for trimethylamine levels.
- Psychological support if necessary.
- Assessment of quality of life and social aspects.
The prognosis for this condition can vary: some patients adapt successfully to lifestyle changes, while others may continue to have severe symptoms. Possible complications include depression, social isolation, and other mental disorders.
Age-related features of the disease
Trimethylaminuria can manifest at any age, but the first symptoms often appear in adolescence or young adulthood. In older people, the symptoms may be less pronounced, but patients may still experience stress and other psychological problems associated with the diagnosis. In children, the disease may not be diagnosed in time, since parents may not associate the smell with a medical problem.
Questions and Answers
- What is trimethylaminuria?
Trimethylaminuria is a genetic disorder characterized by a disorder of trimethylamine metabolism, which leads to the accumulation of this substance in the body and the appearance of an unpleasant odor. - What are the main symptoms of trimethylaminuria?
The main symptoms include an unpleasant fishy odor in sweat and urine, as well as social anxiety and low self-esteem due to the odor. - Can trimethylaminuria be cured?
Treatment involves dietary changes and the use of probiotics and antibiotics; a complete cure is not possible, but symptoms can be controlled. - How is TMAU diagnosed?
Diagnosis includes urine testing for trimethylamine levels and genetic testing for mutations in FMO3. - What are the risk factors for trimethylaminuria?
Risk factors include heredity, consumption of foods rich in trimethylamine, and mutations in the FMO3 gene.
